Pivotal role of the lipid raft SK3-orai1 complex in human cancer cell migration and bone metastases

Cancer Research

Volumn 73, Issue 15, 2013, Pages 4852-4861

  Chantôme, Aurélie ^a   Potier Cartereau, Marie ^a   Clarysse, Lucie ^a   Fromont, Gaëlle ^d,e   Marionneau Lambot, Séverine ^f   Guéguinou, Maxime ^a   Pagés, Jean Christophe ^b,c   Collin, Christine ^c   Oullier, Thibauld ^f   Girault, Alban ^a   Arbion, Flavie ^c   Haelters, Jean Pierre ^g   Jaffrés, Paul Alain ^g   Pinault, Michelle ^a   Besson, Pierre ^a   Joulin, Virginie ^h   Bougnoux, Philippe ^a,c   Vandier, Christophe ^a  

^a CHRU de Tours   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c UNIVERSITY HOSPITAL OF TOURS   (France)

^d POITIERS UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ DE POITIERS   (France)

^f Réseau Epigénétique du Canceropôle Grand Ouest   (France)

^g UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^h INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETASTATIC AGENT; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; CALPAIN; OHMLINE; POTASSIUM CHANNEL; SK3 POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; BREAST CANCER; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MIGRATION; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID RAFT; LUNG METASTASIS; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; BONE NEOPLASMS; CALCIUM CHANNELS; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE MICRODOMAINS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; PATCH-CLAMP TECHNIQUES; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS;

EID: 84881452627     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-4572     Document Type: Article

References (31)

1. Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S, Becchetti A. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr Med Chem 2009;16:66-93.
2. Cuddapah VA, Sontheimer H. Ion channels and transporters [corrected] in cancer. 2. Ion channels and the control of cancer cell migration. Am J Physiol Cell Physiol 2011;301:C541-9.
3. Schwab A, Fabian A, Hanley PJ, Stock C. Role of ion channels and transporters in cell migration. Physiol Rev 2012;92:1865-913.
4. Kohler M, Hirschberg B, Bond CT, Kinzie JM, Marrion NV, Maylie J, et al. Small-conductance, calcium-activated potassium channels from mammalian brain. Science 1996;273:1709-14.
5. Girault A, Haelters JP, Potier-Cartereau M, Chantome A, Jaffres PA, Bougnoux P, et al. Targeting SKCa channels in cancer: potential new therapeutic approaches. Curr Med Chem 2012;19:697-713.
6. Potier M, Joulin V, Roger S, Besson P, Jourdan ML, Leguennec JY, et al. Identification of SK3 channel as a new mediator of breast cancer cell migration. Mol Cancer Ther 2006;5:2946-53.
7. Hosseini R, Benton DC, Dunn PM, Jenkinson DH, Moss GW. SK3 is an important component of K(+) channels mediating the afterhyperpolarization in cultured rat SCG neurones. J Physiol 2001;535:323-34.
8. Chen MX, Gorman SA, Benson B, Singh K, Hieble JP, Michel MC, et al. Small and intermediate conductance Ca(2+)-activated K+ channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum. Naunyn Schmiedebergs Arch Pharmacol 2004;369:602-15.
9. Burnham MP, Bychkov R, Feletou M, Richards GR, Vanhoutte PM, Weston AH, et al. Characterization of an apamin-sensitive smallconductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol 2002;135: 1133-43.
10. Herrera GM,Pozo MJ, Zvara P, Petkov GV, Bond CT, Adelman JP, et al. Urinary bladder instability induced by selective suppression of the murine small conductance calcium-activated potassium (SK3) channel. J Physiol 2003;551:893-903.
11. Taylor MS, Bonev AD, Gross TP, Eckman DM, Brayden JE, Bond CT, et al. Altered expression of small-conductance Ca2+-activated K+ (SK3) channels modulates arterial tone and blood pressure. Circ Res 2003;93:124-31.
12. Chantome A, Girault A, Potier M, Collin C, Vaudin P, Pages JC, et al. KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility. Exp Cell Res 2009;315:3620-30.
13. Girault A, Haelters JP, Potier M, Chantome A, Pinault M, Marionneau- Lambot S, et al. New alkyl-lipid blockers of SK3 channels reduce cancer-cell migration and occurrence of metastasis. Curr Cancer Drug Targets 2011;11:1111-25.
14. Wang ZH, Shen B, Yao HL, Jia YC, Ren J, Feng YJ, et al. Blockage of intermediate-conductance-Ca(2+)-activated K(+) channels inhibits progression of human endometrial cancer. Oncogene 2007;26: 5107-14.
15. Gomez-Varela D, Zwick-Wallasch E, Knotgen H, Sanchez A, Hettmann T, Ossipov D, et al. Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Res 2007;67:7343-9.
16. Monet M, Lehen'kyi V, Gackiere F, Firlej V, Vandenberghe M, Roudbaraki M, et al. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. Cancer Res 2010;70:1225-35.
17. Gu B, Espana L, Mendez O, Torregrosa A, Sierra A. Organ-selective chemoresistance in metastasis from human breast cancer cells: inhibition of apoptosis, genetic variability and microenvironment at the metastatic focus. Carcinogenesis 2004;25:2293-301.
18. Zhang C, Yan Z, Arango ME, Painter CL, Anderes K. Advancing bioluminescence imaging technology for the evaluation of anticancer agents in the MDA-MB-435-HAL-Luc mammary fat pad and subrenal capsule tumor models. Clin Cancer Res 2009;15:238-46.
19. Dvorak MM, Riccardi D. Ca2+ as an extracellular signal in bone. Cell Calcium 2004;35:249-55.
20. Franco SJ, Huttenlocher A. Regulating cell migration: calpains make the cut. J Cell Sci 2005;118:3829-38.
21. Yang S, Zhang JJ, Huang XY. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 2009;15:124-34.
22. Chen YF, Chiu WT, Chen YT, Lin PY, Huang HJ, Chou CY, et al. Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis. Proc Natl Acad Sci U S A 2011;108:15225-30.
23. Pani B, Singh BB. Lipid rafts/caveolae as microdomains of calcium signaling. Cell Calcium 2009;45:625-33.
24. Gajate C, Mollinedo F. Lipid rafts and Fas/CD95 signaling in cancer chemotherapy. Recent Pat Anticancer Drug Discov 2011;6:274-83.
25. Fedida-Metula S, Feldman B, Koshelev V, Levin-Gromiko U, Voronov E, Fishman D. Lipid rafts couple store-operated Ca2+ entry to constitutive activation of PKB/Akt in a Ca2+/calmodulin-, Src- and PP2Amediated pathway and promote melanoma tumor growth. Carcinogenesis 2012;33:740-50.
26. Chambers AF. MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 2009;69:5292-3.
27. Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer.HumMol Genet 2001;10:657-62.
28. Brouard T, Chantome A. Two approaches for automatic nuceli cell countingin lowresolution fluorescence images. In:Computational vision and medical image processing: recent trends. Springer Netherlands; 2011. p. 311-26.
29. Calaghan S, Kozera L, White E. Compartmentalisation of cAMPdependent signalling by caveolae in the adult cardiac myocyte. J Mol Cell Cardiol 2008;45:88-92.
30. Barascu A, Besson P, Le Floch O, Bougnoux P, Jourdan ML. CDK1- cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells. Int J Biochem Cell Biol 2006;38:196-208.
31. Snyder F, Blank ML, Wykle RL. The enzymic synthesis of ethanolamine plasmalogens. J Biol Chem 1971;246:3639-45.